CancerVax Raises $72 Million in IPO
- Share via
From Bloomberg News
CancerVax Corp., a Carlsbad company that is developing cancer treatments, raised $72 million in an initial public offering, selling 6 million shares at $12 each, at the bottom of the $12-to-$14-a-share price range the company had indicated in a Securities and Exchange Commission filing.
CancerVax is testing a treatment for skin cancer.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
